← Open Payments lookup

MELISSA KALENSKY: Open Payments

NPI 1154681591 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,529 in 81 payments from 17 companies in 2025. Trend: 2023 $959 · 2024 $869 · 2025 $1,529

Food & beverage: $1,529
CompanyPaymentsAmount
ABBVIE INC.21$233
E.R. Squibb & Sons, L.L.C.11$207
Lundbeck LLC7$173
Neurocrine BioSciences, Inc.6$162
Vanda Pharmaceuticals Inc.12$156
Otsuka America Pharmaceutical, Inc.4$123
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$100
Janssen Pharmaceuticals, Inc3$96
Axsome Therapeutics, Inc.2$44
Supernus Pharmaceuticals, Inc.2$41

Products named: REXULTI, VRAYLAR, INGREZZA, FANAPT, COBENFY, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.

Industry payments across IL — which companies pay providers there.